Outset Medical Takes $132M For Dialysis Treatment
San Jose-based Outset Medical, which develops technology aimed at reducing the cost and complexity of dialysis, has raised $132M in a Series D funding, the company said this week. The funding was led by Mubadala Investment Company, and also included Baxter Ventures, Fidelity Management and Research Company, Partner Fund Management LP, Perceptive Advisors, funds advised by T. Rowe Price Associates Inc., and Warburg Pincus. Outset Medical said the funding goes towards increasing its production capabilities, and commercial expansion. Leslie Trigg is CEO of Outset Medical.
posted on Friday, August 31, 2018
Related companies:
Outset Medical, Inc.
Related stories:
> Outset Medical Gets $76.5M
> Vertos Medical Raises $12M
> Ample Medical Gets Investment From AGA Medical, Aberdare
> EBR Systems Raises $50M For Wireless Heart Failure Treatment System
> KAI Pharmaceuticals Acquired By Amgen For $315M
silicontap.com Home